AllThingsLifeSciences/CleanTech: 2010

Springboard's 20th Venture Forum Program

About AllThingsLifeSciences/CleanTech: 2010

AllThingsLifeSciences/CleanTech: 2010, Springboard's 20th venture forum, showcased 20 investment ready high-growth companies in biotech, biopharma, health IT, healthcare, medical devices, and diagnostics to an audience of corporate, angel and venture investors. All companies were screened, selected and coached by a committee of over 200 investors, business development professionals, and sector experts during an eight-month period.

Click here to learn more about our venture forums.


 

Who was involved this year...

Forum Sponsors
Supporting Organizations
Forum Committees
Presenting Companies

 

What people are saying...

Click here to see more testimonials.

 

Download materials...

 

 

 

 

 

Supporting Organizations

128 Innovation Capital Group Rockville Economic Development
Astia San Jose Biocenter
Center for Women & Enterprise (CWE) Small Business Television (SBTV)
Cleantech Open Tech Collective
Environmental Business Cluster (EBC) The Capital Network (TCN)
Indiana Health Industry Forum UC Berkeley, Lester Center for Entrepreneurship and Innovation
JumpStart, Inc. University of Florida Office of Technology Licensing
Maryland Biotechnology Center Women Entrepreneurs in Science and Technology (WEST)
Massachusetts Technology Transfer Center Women in Bio (WIB)
MedTech Women's Association of Venture & Equity, Inc. (WAVE)
MichBio

 

 

 

Forum Committees

Investor Committee

Jack Ahrens, TGap Ventures Jahanara Ali, NYC Investment Fund
Richard Anders, Mass Medical Angels (MA2) Ben Auspitz, Fidelity Biosciences
Elizabeth Bailey, Commons Capital Kevin Bitterman, Polaris Venture Partners
Dan Broderick, BioGenerator Mike Bunker, Early Stage Partners
James Burgum, Arthur Ventures Christian Cortis, ATV Capital
Ann Dewitt, Flagship Ventures Cynthia Doerr, Essex Woodlands Health Ventures
Ted Driscoll, Claremont Creek Ventures Suzette Dutch, Triathlon Medical Ventures
Stuart Eckmann, Life Science Angels Teresa Esser, Capital Midwest Fund
Pete Farner, TGap Ventures Lauren Flanagan, Phenomenelle Angels
Nancy Floyd, Nth Power Jennifer Friel Goldstein, Pfizer Inc
Andrew Friendly, ATV Capital Jan Garfinkle, Arboretum Ventures
Karen Hong, ProQuest Investments Eva Jack, Medimmune Ventures
Elaine Jones, Pfizer, Inc. Kef Kasdin, Battelle Ventures
Stephen Kraus, Bessemer Venture Partners Ron Lennox, CHL Medical Partners
Reid Leonard, Merck & Co, Inc. Debra Liebel, Domain Associates
Ellen Lubman, Bristol-Meyers Squibb Michael Lytton, Biogen Idec
Carol Marino, Syngenta Venture Capital Michael Melnick, CMEA Capital
Dan Meyer, Point Judith Capital Pat Morand, SMLS Venture Fund
Todd Morrill, Bio-Rad Laboratories Dana Ono, VIMAC Ventures LLC
Catherine Oyler, Johnson & Johnson William Paiva, Sevin Rosen Funds
Ann Partlow, Earthrise Capital Pooja Pathak, Oxford Bioscience Partners
Susan Rohrer, Merck & Co, Inc. Amita Shukla, New Enterprise Associates
Lauren Silverman, Novartis Venture Capital Karen Spilizewski, RiverVest Venture Partners
Richard Stuebi, Early Stage Partners Geeta Vemuri, BioVentures
Tracy Warren, Battelle Ventures Yael Weiss, Merck & Co, Inc.
Alex Zisson, Thomas McNerney & Partners

Alumnae Committee

Jahan Ali, NYC Investment Fund Jack Ahrens, TGap Ventures
Rajni Aneja, zuChem, Inc. Sylvia Aruffo, Communication Science
Carole Bellis, Wilson Sonsini Karen Bixby
Rachel Braun Scherl, Semprae Laboratories Manny Cho, Aon
Corinne Bright, ONSET Ventures Kirstie Chadwick, Growth Innovators
Ellen Corenswet, Covington & Burling LLP Christian Cortis, ATV Capital
Jacqueline Crespo, Cassidy & Associates Kathleen DeRose, Golden Seeds
Ann Dewitt, Flagship Ventures Mike Diem, SR One
Ted Driscoll, Claremont Creek Ventures Teresa Esser, Capital Midwest Fund
Bill Fair, Ajax Ventures Joan Fallon, Curemark, LLC
Pete Farner, TGap Ventures Lauren Flanagan, Phenomenelle Angels
Barbara Fox, Avaxia Biologics Sara Frankel, Consultant
Jennifer Friel Goldstein, Pfizer Venture Investments Ann Gaddy, Life Science Angels
Gary Gamerman, Seraphim Life Sciences Jan Garfinkle, Arboretum Ventures
Annette Gilchrist, Midwestern University Stephanie Grossman, Digital & Media Executive
Elma, Hawkins, Biotechnology Consultant Diana Hoffman, Hoffman Management Consulting
Karen Hong, ProQuest Investments Mary Howard, Design Technologies, LLC
Nigel Howard, Covington & Burling LLP Kef Kasdin, Battelle Ventures
Stephen Kraus, Bessemer Venture Partners Reid Leonard, Merck & Co., Inc.
Roberta Lee, Manoa Medical, Inc. Donna Lencki, Geneia
Ellen Lubman, Bristol-Meyers Squibb Carol Marino, Syngenta Venture Capital
Deborah Mash, Ibogen, Inc. Patricia Meisner, AdhereTx Corporation
Dan Meyer, Point Judith Capital Jessica Milner, Covington & Burling
Arikha Moses, The Vertical Group Catherine Mulligan, William Gallagher Associates
Carol Nacy, Sequella, Inc. Mike O’Donnell, Wilson Sonsini
Anjali Oberoi, NewSeed Advisors Jill Osur, Blend Tech Solutions
Catherine Oyler, Johnson & Johnson Nancy Parenteau, Parenteau BioConsultants, LLC
Ann Partlow, Earthrise Capital Amy Ravi, ExtendMed
Ingrid Rechtinv, Covington & Burling Karen Spilizewski, RiverVest Venture Partners
LeAnne Tourtellotte, Illinois Technology Association Liat Tsoref, Slender Medical Ltd.
Mary Wallace Jaensch, Semprae Laboratories Sue Washer, Applied Genetic Technologies
Yael Weiss, Merck & Co., Inc. Patti White, Medical Technology
Gervaise Wilhelm, Closys Corporation Donna Williams, Ceres Venture Fund
Alex Zisson, Thomas, McNerney & Partners Diane Zuckerman, Evidence-Based Solutions

CoachingCommittee

Milena Adamian, Easton Capital Jack Ahrens, TGAP Ventures
Jahanara Ali, NYC Investment Fund Rajni Aneja, ZuChem
Elizabeth Bailey, Commons Capital Leslie Bane, National Semiconductor
Susan Berland, Consultant Carlos Berland, Grant Thornton LLP
Anne Marie Biernacki, AdhereTx Corporation Kevin Bitterman, Polaris Ventures
Rachel Braun Scherl, Semprae Laboratories A.G. Breitenstein, Humedica
Corinne Bright, ONSET Ventures Candice Brown Elliot, Nouvoyance Inc.
Mike Bunker, Early Stage Partners Kerry Burke, Covington & Burling LLP
Chris Byrd, Wilson Sonsini Amanda Cashin, Alexandria Real Estate Equities
Maria Casini, Guard Dog Brand Development Vita Cassese, Exigen Capital
Maxine Champion Terry Chase Hazell, Texas State University
Manny Cho, Aon Amy Chu, Tiger Advisors LLC
Martha Connolly, Maryland Technology Enterprise Institute Ellen Corenswet, Covington & Burling LLP
Christian Cortis, ATU Capital Suzanne Cross, Johnson & Johnson
Cynthia Curtis, CA Technologies Bruce Deming, Covington & Burling LLP
Camille DeSantis, Guard Dog Brand Development Ann Dewitt, Flagship Ventures
Brendan Doherty, CA Technologies Ted Driscoll, LSA Member, Claremont Creek
Suzette Dutch, Triathlon Medical Ventures Teresa Esser, Capital Midwest Fund II
Lauren Flanagan, Phenomenelle Angels Carmen Fonda, Venable LLP
Barbara Fox, Avaxia Biologics Jennifer Friel Goldstein, Pfizer Venture Investments
Andrew Friendly, ATV Capital Oren Fuerst, Tevel Angels
Angela Garcia-Lopez, Grant Thornton LLP Megan Gates, Mintz Levin
Judy Giordon, NCIIA Julie Goonewardene, Purdue Research Foundation
Robert Gottlieb, RMG Associates LLC Karin Gregory, Furman Gregory Deptula
Colleen Grimm, William Gallagher Associates Liz Groover
David Guin, Withers Bergman Cal Hackeman, Grant Thornton LLP
Jessica Hall Harrington, Broadview Ventures Elma Hawkins, Consultant
Sarah Hoagland, Covington & Burling LLP Diana Hoffman
Karen Hong, ProQuest Investments Mary Howard, Design Technologies LLC
Nigel Howard, Covington & Burling LLP Dave Hsu, Consultant
Eva Jack, MedImmune Ventures Sven Jacobson, Carrot Capital
Christine Janis, Grant Thornton LLP Elaine Jones, Pfizer Inc.
Veronica Jordon Tanya Kanigan
Kef Kasdin, Battelle Ventures Dr. Hollis Kleinert, KSC Life Science Advisors
Stephan Kraus, Bessemer Venture Partners Roberta Lee, Manoa Medical
Donna Lencki, Geneia Ron Lennox, CHL Medical Partners
Emily Leonard, Covington & Burling LLP Reid Leonard, Merck & Co., Inc.
Scott Levy, Grant Thornton LLP Emily Levy, Synergy Partners
David Lewandoski, Grant Thornton Debra Liebert, Domain Associates
Ellen Lubman, Bristol-Meyers Squibb Joan Lyman
Michael Lytton, Biogen Idec Rob Mashal, Alinea Pharmaceuticals
Andrea McCormick Chris Meda, Arxis Biotechnologies
Kevin Mendelsohn, Jumpstart, Inc. Dan Meyer
Jessica Milner, Covington & Burling LLP Pat Morand, Southwest Michigan First
Todd Morrill, Bio-Rad Laboratories Toby Moskovits, Heritage Equity Partners
Catherine Mulligan Michael Murdoch, Aon
Nalini Murdter Carol Nichols, vcfo
Dana Ono, VIMAC Ventures LLC Jill Osur, Blend Tech Solutions
Cat Oyler, Johnson & Johnson William Paiva, Seven Rosin Funds
Ann Partlow, Earthrise Capital John Perchorowicz, Triage Masters LLC
Amy Ravi, Extend Med Lisa Richardson
Carey Roberts, Covington & Burling LLP Paul Rogers, Covington & Burling LLP
Susan Rohrer, Merck & Co., Inc. Lisa Russell, Grant Thornton
Mira Sahney Ginette Serrero, A & G Pharmaceutical
Christy Shaffer, Inspipre Pharmaceuticals Stefanie Shelley
Emily Sheridan, Alexandria Real Estate Equities Scarlet Shore, Alexandria Real Estate Equities
Lauren Silverman, Novartis Venture Capital JC Simabana, SVB Capital
Brenda Simensky, Withers Bergman Karen Spilizewski, RiverVest Venture Partners
Richard Stuebi, Early Stage Partners Alison Taunton Rigby, RiboNovix Inc.
Lee Tiedrich, Covington & Burling, LLP Alison Tjosvold, Grant Thornton LLP
Amy Toro, Covington & Burling LLP Effie Toshav, Wilson Sonsini
Alexis Traynor Kaplan Liat Tsoref, Slender Medical
Misti Ushio, Harris & Harris Group Inc Geeta Vemuri, Quaker BioVentures
Becky Voorheis Catherine Vorwald, Wexford Science & Technology
Joan Vrtis, Kemeta Mary Wallace Jaensch, Semprae Laboratories
Yael Weiss, Merck & Co Inc Patti White
Amy Wildstein, Boldcap Ventures Donna Williamson, Ceres Venture Fund
Jeff Wu, Covington & Burling LLP Alex Zisson, Thomas McNerny & Partners
Diane Zuckerman, Evidence-Based Solutions